ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ELTP Elite Pharmaceuticals Inc (QB)

0.1765
-0.00485 (-2.67%)
Feb 21 2024 - Closed
Delayed by 15 minutes

Elite Pharmaceuticals (QB) Financial Summary

The current ELTP market cap is 178.96M. The company's latest EPS is USD 0.0035 and P/E is 51.43.

Year End March 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 7.57M18M25.38M32.26M34.16M
Operating Income -9.16M-2.29M2.1M5.07M3.68M
Net Income -9.28M-2.24M5.09M8.9M3.56M
Year End March 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 24.4M24.96M26.19M35.15M40.9M
Total Liabilities 13.01M14.3M10.04M9.93M11.94M
Total Equity -2.51M10.66M16.15M25.22M28.96M

Cash Flow

Year End March 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -6.79M-1.79M3.19M6.51M3.34M
Investing 331k-35k-263k-499k-5.74M
Financing 1.57M690k-870k-667k1.7M
Market Cap 178.96M
Price to Earnings Ratio 51.43
Price to Sales Ratio 5.34
Price to Cash Ratio 23.38
Price to Book Ratio 6.3
Dividend Yield -

Share Statistics

Shares Outstanding 1.01B
Average Volume (1 week) 1.93M
Average Volume (1 Month) 1.52M
52 Week Change 367.55%
52 Week High 0.2119
52 Week Low 0.028
Spread (Intraday) 0.01 (7.05%)

Company Info

Company Name Elite Pharmaceuticals Inc (QB)
Address 321 w. winnie lane
carson city, nevada 89703
Website https://www.elitepharma.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock